首頁 > 市場調查報告書 > 醫療設備

體外診斷

乳房切片市場規模、佔有率和成長分析（按產品、適應症、最終用戶和地區分類）—2026-2033年產業預測

市場調查報告書

商品編碼

1904435

乳房切片市場規模、佔有率和成長分析（按產品、適應症、最終用戶和地區分類）—2026-2033年產業預測

Breast Biopsy Market Size, Share, and Growth Analysis, By Product (Biopsy Needles, Core Needles), By Indication (Complex Cysts, Solid Mass), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，乳房切片市場規模將達到 9.988 億美元，到 2025 年將成長至 10.827 億美元，到 2033 年將成長至 20.6415 億美元，在預測期（2026-2033 年）內複合年成長率為 8.4%。

乳房切片檢查市場是醫療產業中快速成長的細分市場，其成長主要受乳癌發病率上升和人們對早期檢測重要性認知不斷提高的推動。影像和切片檢查技術的進步，以及對微創手術需求的日益成長，正在重塑市場格局。目前，切片檢查方法多種多樣，包括粗針穿刺切片檢查、真空吸引切片檢查、細針穿刺活體組織切片和外科手術，其中影像引導技術因其更高的準確性而顯著應用。此外，切片檢查設備的創新，包括自動化系統和攜帶式設備，正在提高效率和患者舒適度。目前，北美憑藉其完善的醫療保健基礎設施引領市場，但隨著醫療保健支出和意識的提高，新興經濟體預計將迎來顯著成長。

乳房切片市場成長要素

推動乳房切片市場成長的主要因素是全球乳癌發生率的上升。作為最常見的癌症之一，不斷增加的病例數凸顯了早期發現和適當干預的重要性。人們對識別乳房異常的日益關注，導致對乳房活體組織切片的需求激增，而乳房切片對於準確診斷至關重要。隨著醫療機構尋求有效策略來應對這一日益嚴重的健康問題，對可靠、準確的診斷技術的需求也顯著促進了乳房切片市場的擴張。

限制乳房切片市場的因素

全球乳房切片市場面臨的一大挑戰是假陰性和假陽性結果的出現。乳房切片對於識別乳癌至關重要，但同時也存在結果不準確的風險。假陰性結果可能導致癌細胞漏診，延誤診斷。另一方面，假陽性結果可能會給患者帶來不必要的壓力、額外的檢查，甚至侵入性手術。這些診斷準確性問題會削弱人們對乳房切片有效性的信心，並使醫護人員和患者在選擇合適的治療方案時面臨更複雜的決策流程。

乳房切片市場趨勢

乳房切片領域的一個顯著市場趨勢是影像引導切片檢查技術的日益普及。超音波引導、乳房X光攝影引導和磁振造影引導等切片檢查因其能夠更精準地定位可疑乳房病灶而廣泛應用。這些技術應用先進的影像模式，在顯著提高診斷準確性的同時，與傳統方法相比具有微創性。即時影像的整合能夠更清晰地顯示病灶區域，從而提高診斷效率並減少重複檢查的需求。這一趨勢凸顯了業界致力於提升乳房切片手術效率、病患舒適度和整體安全性的決心。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Hologic, Inc.（USA）
Danaher Corporation（USA）
Becton, Dickinson and Company（BD）（USA）
Argon Medical Devices（USA）
Merit Medical Systems（USA）
Menarini-Silicon Biosystems（Italy）
Guardant Health, Inc.（USA）
NeoGenomics（USA）
Sysmex Inostics（Germany）
Ethicon Endo-Surgery, Inc.（USA）
CR Bard, Inc.（USA）
Leica Biosystems Nussloch GmbH（Germany）
Encapsule Medical Devices LLC（USA）
Intact Medical Corporation（USA）
Galini SRL（Italy）
Cook Medical Incorporated（USA）
Medtronic plc（Ireland）
Devicor Medical Products, Inc.（USA）
Carestream Health, Inc.（USA）
Planmed Oy（Finland）

結論與建議

簡介目錄

Product Code: SQMIG35A2467

Breast Biopsy Market size was valued at USD 998.8 Million in 2024 and is poised to grow from USD 1082.7 Million in 2025 to USD 2064.15 Million by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).

The breast biopsy market is a rapidly expanding segment of the healthcare industry, driven by the rising incidence of breast cancer and increased awareness of the importance of early detection. Technological advancements in imaging and biopsy techniques, coupled with a preference for minimally invasive procedures, are shaping the landscape. Various biopsy methods such as core needle, vacuum-assisted, fine needle aspiration, and surgical techniques are being utilized, with a noticeable shift towards image-guided procedures that enhance accuracy. Moreover, innovations in biopsy devices, including automated systems and handheld options, are enhancing efficiency and patient comfort. While North America currently leads the market due to its robust healthcare infrastructure, significant growth is anticipated in emerging economies as healthcare expenditures rise and awareness increases.

Top-down and bottom-up approaches were used to estimate and validate the size of the Breast Biopsy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Breast Biopsy Market Segments Analysis

Global Breast Biopsy Market is segmented by product, indication, end user and region. Based on product, the market is segmented into biopsy needles, MRI guide biopsy systems, ultrasound guided breast biopsy system, vacuum assisted devices, guide wire and breast biopsy markers. Based on indication, the market is segmented into complex cysts, solid mass, suspicious solid mass and suspicious micro calcifications. Based on end user, the market is segmented into hospitals, specialty clinics and cancer research institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Breast Biopsy Market

A major catalyst for the growth of the Breast Biopsy Market is the rising prevalence of breast cancer across the globe. As one of the most frequently diagnosed cancers, the increasing cases have drawn attention to the importance of early detection and timely intervention. This heightened focus on identifying breast abnormalities has led to a surge in demand for breast biopsy procedures, which are crucial for accurate diagnosis. The necessity for dependable and precise diagnostic methods has played a significant role in expanding the breast biopsy market, as healthcare providers seek to implement effective strategies for managing this growing health concern.

Restraints in the Breast Biopsy Market

A significant challenge facing the global breast biopsy market is the occurrence of false-negative and false-positive results. While breast biopsies are essential for identifying breast cancer, there is a risk of inaccurate outcomes. False-negative results can lead to undetected cancerous cells, resulting in delayed diagnoses, while false-positive outcomes may subject patients to undue stress, extra testing, and even invasive procedures. These issues regarding diagnostic precision can diminish trust in the effectiveness of breast biopsy methods, complicating the decision-making process for both healthcare providers and patients in determining appropriate treatment options.

Market Trends of the Breast Biopsy Market

A prominent market trend within the breast biopsy sector is the escalating preference for image-guided biopsy techniques. Technologies such as ultrasound-guided, mammography-guided, and MRI-guided biopsies have garnered widespread acceptance due to their ability to enhance the precision of targeting suspicious breast lesions. By leveraging advanced imaging methods, these techniques significantly improve diagnostic accuracy while minimizing invasiveness compared to traditional approaches. The integration of real-time imaging allows for superior visualization of the area of concern, resulting in higher diagnostic yields and reducing the necessity for repeat procedures. This trend underscores the industry's commitment to advancing procedural efficiency, patient comfort, and overall safety in breast biopsy practices.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Breast Biopsy Market Size by Product & CAGR (2026-2033)

Market Overview
Biopsy Needles
- Core Needles
- Fine Aspiration Needles
Mri Guide Biopsy Systems
Ultrasound Guided Breast Biopsy System
- 2D Mammographic Ultrasonic Scanning Systems
- 3D B-Mode Mammographic Ultrasonic Scanning Systems
Vacuum Assisted Devices
Guide Wire
Breast Biopsy Markers

Global Breast Biopsy Market Size by Indication & CAGR (2026-2033)

Market Overview
Complex Cysts
Solid Mass
Suspicious Solid Mass
Suspicious Micro Calcifications

Global Breast Biopsy Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Specialty Clinics
Cancer Research Institutes

Global Breast Biopsy Market Size & CAGR (2026-2033)

North America (Product, Indication, End User)
- USA
- Canada
Europe (Product, Indication, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Indication, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Indication, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Indication, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Hologic, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Argon Medical Devices (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Menarini-Silicon Biosystems (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guardant Health, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeoGenomics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Inostics (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ethicon Endo-Surgery, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
C. R. Bard, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Leica Biosystems Nussloch GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Encapsule Medical Devices LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intact Medical Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Galini SRL (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Devicor Medical Products, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Carestream Health, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Planmed Oy (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments